Research Links Popular Weight Loss Drugs to Nail and Hair Changes

Scientists have found a connection between popular weight loss medicines and changes to nails, hair, and the scalp. This research was shared at a medical meeting in 2026. It marks the first controlled study looking at this specific relationship.

The medicines studied belong to a group called GLP-1 receptor agonists. Specific brands mentioned include Ozempic, Wegovy, Mounjaro, and Zepbound. These are used for weight loss and type 2 diabetes management.

Researchers compared two groups of people for this study. One group took GLP-1 medications while the other had diabetes or obesity but did not use these drugs. The study included hundreds of participants from France, the United States, Brazil, and Mexico.

The results showed much higher rates of nail problems in the medication group. About 39% of users reported nail detachment, a condition in which the nail separates from the skin underneath. In contrast, only about 9% of people who never took the drugs experienced this issue.

Hair and scalp issues were also more common among drug users. Half of the GLP-1 group reported unusual hair loss compared to just 34% of those not using the medication. Scalp redness appeared about three times more often in people taking the drugs.

Scientists wanted to know if weight loss alone caused these changes. Rapid weight change can affect body processes and nutrition. However, the data showed that dropping pounds did not fully explain the differences in nail or hair health.

Some participants had skin or nail issues before starting treatment. When researchers accounted for these existing conditions, the gap between groups narrowed but remained significant. Nail detachment was still two to three times more common among users even after adjustments were made.

The study relied on reports from participants rather than clinical exams. This means it shows a pattern but cannot prove the drugs directly caused the problems. Doctors advise patients not to stop treatment on their own if changes occur.

Researchers plan to follow patients over time in future investigations. These studies will use standardized checks to track when symptoms appear and why they happen. They hope to find out if the conditions improve or disappear with continued use.